Applying Lessons Learned from COVID-19 Research and Development to Future Epidemics: A Workshop

Workshop

Download PDF

Paperback - $23.40
Ebook - $18.89

Request an exam or desk copy

The COVID-19 pandemic catalyzed unparalleled speed and cross-sector collaboration in the innovation of tools and technologies to address an emerging infectious disease outbreak. Continued innovation and collaboration in rapid development and implementation of new vaccines, therapeutics, and diagnostics is central to future outbreak preparedness. The National Academies Forum on Microbial Threats; Forum on Drug Discovery, Development, and Translation; and the Forum on Medical and Public Health Preparedness for Emergencies and Disasters held a workshop in December 2022 to explore how innovative approaches in research can enhance health systems preparedness and responses to emerging infectious diseases and dangerous pathogens. Workshop participants reflected on critical scientific infrastructure for stakeholder coordination and innovations that can facilitate rapid and effective preparedness and response to emerging infectious disease threats. This Proceedings of a Workshop summarizes the discussions held during the workshop.

Publication information

172 pages · 6 x 9 · paperback
ISBN Paperback: 0-309-70784-6
ISBN Ebook: 0-309-70785-4
DOI: https://doi.org/10.17226/27194

Suggested citation

National Academies of Sciences, Engineering, and Medicine. 2023. Applying Lessons Learned from COVID-19 Research and Development to Future Epidemics: Proceedings of a Workshop. Washington, DC: The National Academies Press.

Import this citation to:

Timothy Burgess

Timothy Burgess, M.D., M.P.H., is a physician-scientist, infectious diseases specialist, and retired U.S. Navy medical officer, recently completing service as Director of the Infectious Disease Clinical Research Program at Uniformed Services University in Bethesda. His research and clinical experience over the past 28 years have encompassed emerging and re-emerging infectious diseases particularly important to human health. He previously served as investigator and department head at the Naval Medical Research Center in Silver Spring, MD and at Naval Medical Research Unit #2 in Jakarta, Indonesia; and as director of the US Military’s dengue vaccine program. His research has focused on immunopathogenesis and epidemiology of viral diseases including influenza, COVID-19, and arboviral diseases. He served as Chief of the Infectious Diseases Clinical Service at Walter Reed National Military Medical Center (WRNMMC), Bethesda from 2012 – 2016 and established the Enhanced Precautions Unit at WRNMMC, developing the Defense Health Agency’s capability for management of patients with high-consequence pathogens including Ebolavirus disease. He has served as a technical advisor to US Department of Defense and Interagency working groups in support of the US Federal Covid-19 Response; as a member of the U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee; and as DOD representative ex officio to the National Institutes of Health (NIH) Covid-19 Treatment Guidelines Panel.

Jon H. Heinrichs

Jon Heinrichs, Ph.D., is an Associate Vice President and the Head of Innovation and Emerging Sciences at Sanofi Pasteur in Swiftwater, PA and serves as the Global Project Head for nirsevimab, a next generation RSV monoclonal antibody in late-stage development in collaboration with AstraZeneca. Prior to joining Sanofi, Dr. Heinrichs headed the Microbial Vaccine Research group at Merck Research Labs where he led a team of scientists developing vaccines for several bacterial pathogens. Dr. Heinrichs previously held positions of increasing responsibility at the biotechnology company MedImmune (now part of AstraZeneca), where he contributed to the identification of vaccine candidates and was involved in research on the efficacy of monoclonal antibodies for the prevention of infectious diseases and the treatment of cancer and inflammatory diseases. Dr. Heinrichs earned his doctoral degree in microbiology and molecular genetics from Rutgers University and the University of Medicine and Dentistry of New Jersey and completed a post-doctoral fellowship in the Laboratory of Bacterial Pathogenesis and Immunology at The Rockefeller University.

Dolores Albarracin

Dolores Albarracín, Ph.D., M.S., is a social psychologist who studies social cognition and behavioral change. She is a fellow of the Society for Social and Personality Psychology, American Psychological Association, the Association for Psychological Science, and the Society for Experimental Social Psychology, and the American Academy of Political and Social Science. Her research (~ 200 publications) has been recognized with an award for Outstanding Mid-Career Contributions to the Psychology of Attitudes and Social Influence and the Diener Award to Outstanding Mid-Career Contributions to Social Psychology from the Society of Social and Personality Psychology, as well as an Avant Garde Award from the National Institutes of Health. She has published six books, with include three volumes of the Handbook of Attitudes and two authored monographs: Action and Inaction in a Social World: Predicting and Changing Attitudes and Behaviors (2021) and Creating Conspiracy Beliefs: How Our Thoughts are Shaped (2022), both published by Cambridge University Press. She was Editor-in-chief of Psychological Bulletin from 2014 to 2020, and is President-Elect of the Society for Personality and Social Psychology for 2023 and incoming editor of the Journal of Personality and Social Psychology: Attitudes and Social Cognition.

Dan H. Barouch

Dan Barouch, M.D., Ph.D., received his Ph.D. in immunology from Oxford University and his M.D. from Harvard Medical School. He is currently the William Bosworth Castle Professor of Medicine and Professor of Immunology at Harvard Medical School, Director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, a member of the Ragon Institute of MGH, MIT, and Harvard, and part of the Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery. His laboratory focuses on studying the immunology and pathogenesis of viral infections and developing novel vaccine and treatment strategies. His group has led the development of vaccine candidates for multiple pathogens of global significance, including HIV, Zika virus, tuberculosis, and most recently SARS-CoV-2. His recent work contributed to the development of the Johnson & Johnson COVID-19 vaccine and the evaluation of multiple COVID-19 vaccines and monoclonal antibody therapeutics. He was elected to the National Academy of Medicine in 2020.

Daniel Bausch

Daniel Bausch, M.D., M.P.H., is the President of the American Society of Tropical Medicine and Hygiene; Senior Director for Emerging Threats and Global Health Security at FIND, the global alliance for diagnostics; and a Professor of Tropical Medicine at the London School of Hygiene and Tropical Medicine (LSHTM). Previously, he served as Director of the United Kingdom`s Public Health Rapid Support team (2017-21), a joint effort by Public Health England and LSHTM to respond and conduct research to prevent and control outbreaks of dangerous infectious diseases around the world. He has also held posts at the World Health Organisation in Geneva, Switzerland; U.S. Naval Medical Research Unit No. 6 in Lima, Peru; Tulane School of Public Health and Tropical Medicine in New Orleans, USA; and the U.S. Centers for Disease Control and Prevention in Atlanta, USA. Dr Bausch is an internationally recognized leader in the research and control of emerging tropical viruses, with over 25 years’ experience in sub-Saharan Africa, Latin America, and Asia combating viruses such as Ebola, Lassa, hantavirus, and SARS coronaviruses. He places a strong emphasis on capacity development in all his projects and has a keen interest in the role of the scientist in promoting health and human rights. He is trained in internal medicine, infectious diseases, tropical medicine, and public health. Dr Bausch is fluent in English, French and Spanish.

Theresa Bernardo

Theresa Bernardo, D.V.M., M.Sc., is a globally connected innovator in addressing complex health problems through technology with more than a decade of experience in the United Nations and Inter-American systems in health informatics (humans/food/animals/plants), and another decade in academia. In her role as IDEXX Chair in Emerging Technologies and Preventive Healthcare at the University of Guelph’s Ontario Veterinary College (OVC), Bernardo focuses on the intersection of health and information technology, more broadly referred to as health informatics. She and her research team tackle challenges related to access and integration of veterinary health data from various sources, demonstrating practical use of data for patient health monitoring and preparing veterinarians for success in a tech-enabled world.

Ambika Bumb

Ambika Bumb, Ph.D., An entrepreneur with a background in nanomedicine, Dr. Ambika Bumb professional path has bridged academia, industry, and government. She is currently the Deputy Executive Director of the Bipartisan Commission on Biodefense which is working to institute long-lasting programs and policies to protect from biothreats such as pandemics. She has also served as President Biden’s Deputy Executive Director of the President’s Council of Advisors on Science and Technology; Health, Science, and Technology Advisor for Secretary of State’s Crisis Management and Strategy; Board Member for the International Biomedical Research Alliance; Strategic Advisor to the Energy Sciences Area of Berkeley Lab; and CEO of the biotech Bikanta. During the COVID-19 pandemic, Dr. Bumb and her team at the Department of State were awarded the Distinguished Honor Award for exceptionally outstanding service of marked international significance. The Senate unanimously passed the bipartisan Resolution 567 commending their efforts in bringing home more than 100,000 citizens during the COVID-19 pandemic, the largest repatriation effort in U.S. history. She received the NIH’s Orloff Technical Advance Award for her work on a “platform” technology with implications that will broadly advance medicine on multiple fronts. Her research has led to 16 patents, the spinout of the biotech Bikanta, and was named one of 40 under 40 influential Bay Area business leaders. She graduated from Georgia Tech with a B.Sc. in Biomedical Engineering, obtained her doctorate from the University of Oxford while on the Marshall Scholarship, and completed fellowships at the National Cancer Institute and National Heart, Lung and Blood Institute.

Andrew Clements

Andrew Clements, Ph.D., is a Senior Scientific Advisor for the Emerging Threats Division in the U.S. Agency for International Development’s Bureau for Global Health. He received his Ph.D. in Anaerobic Microbiology from Virginia Tech and completed his post-doctoral training in biochemistry at the National Institutes of Health. Between 1997 and 2005, he served as an infectious disease advisor at USAID focusing on the development, management, and monitoring of international programs to address malaria, tuberculosis, antimicrobial resistance, and infectious disease surveillance. Since 2005, he has managed a number of projects (PREDICT, PREVENT) and partnerships with the Food and Agriculture Organization of the UN and the World Health Organization that support prevention, detection, and response to emerging zoonotic threats in developing countries. He also analyzes trends for emerging zoonotic threats and has participated in USAID’s responses to new diseases, including H5N1 and H7N9 avian influenza, H1N1 pandemic influenza, MERS-CoV, and Ebola.

Elizabeth D. Hermsen

Elizabeth Hermsen, Pharm.D., M.B.A., is the Lead for Global Antimicrobial Resistance & Antimicrobial Stewardship Medical Affairs at Pfizer and an Adjunct Associate Professor at the University of Nebraska Medical Center, Colleges of Pharmacy and Medicine, in Omaha, Nebraska. Dr. Hermsen received her Doctor of Pharmacy degree from the University of Nebraska Medical Center followed by a pharmacy practice residency at The Nebraska Medical Center, a fellowship in Infectious Diseases Research at the University of Minnesota, College of Pharmacy, and a master’s degree in business administration at the University of Minnesota, Carlson School of Management. Following her fellowship, Dr. Hermsen developed and co-directed the antimicrobial stewardship program at The Nebraska Medical Center and then joined Cubist, where she held medical affairs and outcomes research roles and created and led the Antimicrobial Stewardship Outreach Group. Subsequently, Dr. Hermsen was a Global Health Equity Director and the Head of Global Antimicrobial Stewardship at Merck & Co., Inc., where she was responsible for supporting efforts to improve equitable outcomes and creating and executing a strategy to advance antimicrobial stewardship through education, implementation, research, and advocacy, with a global scope, across human, animal, and environmental health. Now, in her role at Pfizer, she is responsible for leading the development and implementation of the antimicrobial stewardship medical strategy. Dr. Hermsen is a Fellow of the Society of Infectious Diseases Pharmacists (SIDP) and the Infectious Diseases Society of America (IDSA). She currently serves on the SIDP Policy & Government Affairs Committee, the IDSA Leadership Development Committee, and the Scientific Advisory Committee for the Antimicrobial Stewardship Project at the Center for Infectious Diseases Research and Policy. She has contributed to the profession with numerous publications in peer-reviewed journals, book chapters, and by serving as a reviewer for several professional journals. Dr. Hermsen has given over 100 invited presentations at state, regional, national, and international meetings, and she gave a TED talk regarding antimicrobial stewardship and resistance at TEDx Omaha 2019.

Kent E. Kester

Kent Kester, M.D., is currently Vice President, Translational Medicine, at IAVI. During a 24-year career in the US Army, he worked extensively in clinical vaccine development and led multiple research platforms at the Walter Reed Army Institute of Research, the U.S. Department of Defense’s largest and most diverse biomedical research laboratory with a major emphasis on emerging infectious diseases, an institution he later led as its Commander. His final military assignment was as the Associate Dean for Clinical Research in the School of Medicine at the Uniformed Services University of the Health Sciences (USUHS). During his military service, Dr. Kester was appointed as the lead policy advisor to the US Army Surgeon General in both Infectious Diseases and in Medical Research & Development. More recently, he served as the head of translational medicine and biomarkers at Sanofi Pasteur. Dr. Kester holds an undergraduate degree from Bucknell University and an M.D. from Jefferson Medical College, completing his internship and residency in internal medicine at the University of Maryland and a research fellowship in infectious diseases at the Walter Reed Army Medical Center. Currently a member of the Department of Veterans Affairs Health Services Research & Development Service Merit Review Board, the National Academy Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats, and the CEPI Scientific Advisory Committee, he previously chaired the Steering Committee of the NIAID/USUHS Infectious Disease Clinical Research Program, and has served as a member of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB), the FDA Vaccines & Related Biologics Products Advisory Committee (VRBPAC), the NIAID Advisory Council, and the CDC Office of Infectious Diseases Board of Scientific Counselors. He is the Vice Chair of the National Academy of Medicine Forum on Microbial Threats. Board-certified in both internal medicine and infectious diseases, Dr. Kester holds faculty appointments at USUHS and the University of Maryland; and is a fellow of the American College of Physicians, the Royal College of Physicians of Edinburgh, the Infectious Disease Society of America, and the American Society of Tropical Medicine and Hygiene. He is a member of the clinical faculty at the University of Maryland Shock Trauma Center in Baltimore and the Wilkes-Barre VA Medical Center in Wilkes-Barre, PA.

Jason Newland

Jason Newland, M.D., M.Ed., focuses on the appropriate use of antimicrobials in all settings, including both human and animal health. His primary research focus has been in the dissemination and implementation of Antimicrobial Stewardship Programs for hospitalized children. He is the founder and leader of the Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS) national collaborative of over 50 children’s hospitals across the United States. Additionally, he is involved with implementing strategies to improve antibiotic use in the ambulatory setting. His advocacy work has been in promoting appropriate antibiotic use in the agriculture industry. In 2022, the Department of Pediatrics at Washington University School of Medicine in St. Louis named Newland vice chair of community health and strategic planning. He also treats patients at St. Louis Children’s Hospital and is frequently featured as a health care expert answering viewer questions on KSDK-TV in St. Louis.

John Parrish-Sprowl

John Parrish-Sprowl, Ph.D., M.A., currently serves as the Director of the Global Health Communication Center (GHCC) of the Indiana University School of Liberal Arts as well as professor of Communication Studies and adjunct professor of Women, Gender, and Sexuality Studies. Prior to this position, he was the Chair of the Department of Communication Studies and a founding member of the Clinical and Translational Science Institute Community Health Engagement Program in the IU School of Medicine. In addition, he is a member of the IU Center for Global Health, University College, and Russian and Eastern Europe Institute faculties of Indiana University. Professor Parrish-Sprowl has been elected to the legislative Assembly of the National Communication Association, twice as Chair of the Applied Communication Division. He serves as a research associate of the Center for Intercultural New Media Research (CINMR), the CMM Institute and is on the WHO roster of experts for social and behavioral change.

Dr. Parrish-Sprowl has worked with WHO and various Ministries of Health in the areas of risk communication, radiation emergency response guidelines, the development of communication strategy to increase influenza vaccine uptake, and in the development of complex approaches to community engagement. Dr. Parrish-Sprowl has served as a Fulbright Senior Specialist and has been honored with awards from various organizations as well as his current, and past universities, including the Indiana University Bicentennial Medal, John W. Ryan award for international service, The University Gold Medal and the Scholar of Distinction in Social Sciences from the University of Wroclaw (Poland).

Carla Saenz

Carla Saenz, Ph.D., is the Regional Bioethics Advisor at the Pan American Health Organization (PAHO), which is the World’s Health Organization's Regional Office for the Americas. She is responsible for PAHO’s Regional Program on Bioethics, which provides support on bioethics to countries in Latin America and the Caribbean, e.g., strengthening national research ethics systems, integrating ethics in health-related work, and advancing capacity on bioethics. An elected fellow of the Hastings Center, she has been responsible for the development of PAHO’s Zika and COVID-19 ethics guidance documents, including Catalyzing Ethical Research in Emergencies. Ethics Guidance, Lessons Learned from the COVID-19 Pandemic, and Pending Agenda. Dr. Saenz serves on the board of the International Association of Bioethics (IAB) and the Steering Committee of the Global Forum on Bioethics in Research (GFBR). She holds a PhD in Philosophy from the University of Texas at Austin and, before joining PAHO, she was at the Department of Bioethics at Clinical Center of the National Institutes of Health (NIH), and in the faculty in the Philosophy Department at the University of North Carolina at Chapel Hill.

Matthew Zahn

Matthew Zahn, M.D., currently serves as the Deputy Health Officer and the Medical Director for the Communicable Disease Control Division of the Orange County Health Care Agency. He is also Adjunct Professor in the Division of Pediatric Infectious Diseases for the University of California-Irvine Department of Pediatrics. Dr. Zahn received his doctorate in medicine from St. Louis University School of Medicine and completed his Pediatric Infectious Disease Fellowship at the Children’s Hospital of Colorado. From 2004 through 2011, he served as medical director for the Louisville Metro Department of Public Health and Wellness. During that time, he also served as an assistant professor of pediatric infectious disease at the University of Louisville School of Medicine. Since 2008, Dr. Zahn has served on behalf of the National Association of County and City Health Officials as the liaison to the CDC’s Advisory Committee of Immunization Practices. From 2017-2018, he was President of the California Association of Communicable Disease Controllers. From 2016-2019, he served as Chair of the Infectious Diseases Society of America’s Public Health Workgroup.

Log In

Sign in to access your saved publications, downloads, and email preferences.

Former MyNAP users: You'll need to reset your password on your first login to MyAcademies. Click "Forgot password" below to receive a reset link via email. Having trouble? Visit our FAQ page to contact support.

Members of the National Academy of Sciences, National Academy of Engineering, or National Academy of Medicine should log in through their respective Academy portals.

Email (required)
Password (required)

Don't have an account?

Register

Email (required)
New password (required)
Retype password (required) Password must be at least 8 characters
I accept the terms of use
terms of use

Thank You

Thank you for creating a MyAcademies account!

Enjoy free access to thousands of National Academies' publications, a 10% discount off every purchase, and build your personal library.

Forgot Password

Enter the email address for your MyAcademies (formerly MyNAP) account to receive password reset instructions.

Reset Requested

We sent password reset instructions to your email . Follow the link in that email to create a new password. Didn't receive it? Check your spam folder or contact us for assistance.

Reset Password

New password (required)
Retype password (required) Password must be at least 8 characters

Reset Password

Your password has been reset.

Log In

Verify email

Verify Your Email Address

We sent a verification link to your email. Please check your inbox (and spam folder) and follow the link to verify your email address. If you did not receive the email, you can request a new verification link below

Subscribe

First Name
Last Name
Email (required)
I agree to receive emails from the National Academies (required)

We respect your privacy and will never share your information.

Applying Lessons Learned from COVID-19 Research and Development to Future Epidemics: A Workshop

Featured publication

Description

Collaborators

Committee

Sponsors

Staff

Parent projects

Board on Global Health

Forum on Microbial Threats

Forum on Drug Discovery, Development, and Translation

Forum on Medical and Public Health Preparedness for Disasters and Emergencies

Major units and sub-units

Contact

Provide feedback

Request materials

More like this

Forum on Drug Discovery, Development, and Translation

Transit Cooperative Research Program

National Cooperative Highway Research Program

Prevention of and Response to Sexual Harassment in Higher Education: Tools for Department Chairs and Principal Investigators: A Workshop

Health Care Financing to Improve Availability of Affordable Contraception: Identifying Promising Practices

Review of Methods in the Report on Carcinogens Handbook

Exploring Relevant Policy Domains — Housing Policy and Population Health: A Workshop

Publication information

Suggested citation

My Academies

Applying Lessons Learned from COVID-19 Research and Development to Future Epidemics: A Workshop

Dropdown items

Featured publication

Applying Lessons Learned from COVID-19 Research and Development to Future Epidemics: Proceedings of a Workshop

Description

Collaborators

Committee

Sponsors

Staff

Parent projects

Board on Global Health

Forum on Microbial Threats

Forum on Drug Discovery, Development, and Translation

Forum on Medical and Public Health Preparedness for Disasters and Emergencies

Major units and sub-units

Contact

Provide feedback

Request materials

More like this

Forum on Drug Discovery, Development, and Translation

Transit Cooperative Research Program

National Cooperative Highway Research Program

Prevention of and Response to Sexual Harassment in Higher Education: Tools for Department Chairs and Principal Investigators: A Workshop

Health Care Financing to Improve Availability of Affordable Contraception: Identifying Promising Practices

Review of Methods in the Report on Carcinogens Handbook

Exploring Relevant Policy Domains — Housing Policy and Population Health: A Workshop